“someday you will learn that HM is bullcrap
even if it works it wont work on everyone, THERE IS NO CURE FOR BALDNESS
EINSTEIN, and there never will be”
In the verbiage above, Hangininthere has revealed his editorial position on the subject of gene-therapy, wnt-wounding techniques, ACELL injections, Aderans, Intercytex, Phoenixbio (Japanese), and Shishedo’s (Japanese) research into the area of male pattern baldness and its treatment and further prevention.
If one really thinks “there never will be” anything effective to grow hair in balding areas other than manual transplantaion…the HM forum should be a pretty moot place to even read or visit.
A word on the people working on HM and other would-be therapies:
Here is the research team of follica (of which Kurt Stenn and George Costarialis are also involved):
http://www.puretechventures.com/content/team.asp?mainPage=team&subPage=all#
You can click on the peoples pictures and read their credidentials like this man:
Dr. John Zabriskie
Co-Founder, Partner
Dr. Zabriskie, a co-founder and Partner of PureTech. He is past chairman of the board, CEO and president of NEN Life Science Products, Inc., a leading supplier of kits for labeling and detection of DNA. At NEN Dr. Zabriskie led the successful turnaround and sale of the company in a transaction that generated 20x return for the investors that backed him. Prior to joining NEN, Dr. Zabriskie was President and CEO of Pharmacia and Upjohn, Inc., a Fortune 500 pharmaceutical company formed by the merger of Pharmacia AB of Sweden and the Upjohn Company of Kalamazoo, Michigan. As Chairman of the Board and CEO of the Upjohn Company, Dr. Zabriskie led the Upjohn project, which resulted in the $12 billion merger of equals. Prior to joining Upjohn in 1994, Dr. Zabriskie was Executive Vice President of Merck and Co., Inc. Dr. Zabriskie was a member of the US Healthcare Leadership Council, and has served on a number of boards for healthcare and academic institutions including being one of the founding investors and board members of Momenta. He currently serves on the boards of the Kellogg Co., Cellicon Biotechnologies, Protein Forest, Array BioPharma, and ARCA Discovery. Dr. Zabriskie is a native of Aurora, NY and received his AB in chemistry from Dartmouth College in 1961 and his PhD in organic chemistry from the University of Rochester (NY) in 1965.
or this man:
Dr. Shapiro is a Partner of PureTech. He was most recently Executive Vice President, Worldwide Licensing and External Research for Merck. He joined Merck Research Laboratories in September 1990 as Executive Vice President, Basic Research, Merck Research Laboratories. In this position he was responsible for all the basic and preclinical research activities at Merck worldwide. Dr. Shapiro led the research program that resulted in FDA registration of approximately 20 drugs and vaccines -including Vioxx and Arcoxia (Cox 2 inhibitors) and Emend, going back as far as the A2 antagonist Cozaar, hepatitis A vaccine VACQTA, and many others. From 1999-2003 Shapiro oversaw all in-licensing activities for Merck. Previously, he was Professor and Chairman of the Department of Biochemistry at the University of Washington. He is the author of over 120 papers on the molecular regulation of cellular behavior and the biochemical events that integrate the cascade of cellular activations at fertilization. He has served on many institutional advisory boards and scientific review panels, and is currently a member of the board of VBL, Protein Forest Inc., Momenta, Elixir, and Ikaria and serves on the Harvard - MIT Division of Health Sciences & Technology Advisory Committee
or this man:
Dr. Langer is a co-founder and Partner of PureTech Ventures. Dr. Langer is known for his groundbreaking discoveries in the fields of polymer chemistry, controlled drug delivery, and tissue engineering. He is one of 13 Institute Professors (the highest honor awarded to a faculty member) at the Massachusetts Institute of Technology (MIT). Dr. Langer has written over 950 articles and also has more than 600 issued or pending patents worldwide, one of which was cited as the outstanding patent in Massachusetts in 1988 and one of 20 outstanding patents in the United States. Dr. Langer has received nearly 150 major awards.
In 2007, he received the 2006 United States National Medal of Science. In 2002, he received the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers and the world’s most prestigious engineering prize, from the National Academy of Engineering. He is also the only engineer to receive the Gairdner Foundation International Award; 68 recipients of this award have subsequently received a Nobel Prize. Among numerous other awards, Dr. Langer has received are the Dickson Prize for Science (2002), Heinz Award for Technology, Economy and Employment (2003), the Harvey Prize (2003), the John Fritz Award (2003) (given previously to inventors such as Thomas Edison and Orville Wright), the General Motors Kettering Prize for Cancer Research (2004), the Dan David Prize in Materials Science (2005) and the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research. In 2006, he was inducted into the National Inventors Hall of Fame. In 1998, he received the Lemelson-MIT prize, the world’s largest prize for invention for being “one of history’s most prolific inventors in medicine.” In 1989 Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences. He is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction.
Forbes Magazine (1999) and BioWorld (1990) have named Dr. Langer as one of the 25 most important individuals in biotechnology in the world. Discover Magazine (2002) named him as one of the 20 most important people in this area. Forbes Magazine (2002) selected Dr. Langer as one of the 15 innovators world wide who will reinvent our future. Time Magazine and CNN (2001) named Dr. Langer as one of the 100 most important people in America and one of the 18 top people in science or medicine in America. Dr. Langer has served, at various times, on 15 boards of directors and 30 Scientific Advisory Boards of such companies as Wyeth, Alkermes, Mitsubishi Pharmaceuticals, Warner-Lambert, and Momenta Pharmaceuticals. Dr. Langer has received honorary doctorates from Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), the University of Liverpool (England), the University of Nottingham (England), Albany Medical College, the Pennsylvania State University, Northwestern University and Uppsala University (Sweden). He received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.
Im not even going to go into Dr. Paul Kemp, the man who created the world’s first organ from cells, or Ken Washenik, or Kurt Stenn, or George Costarailis, or Angela Christiano, etc.
Who are YOU going to believe?
These EMINENT scientists and researchers, or some guy on the internet who takes saw palmetto and a hair vitamin?